LON:OXP Oxford Pharmascience Group (OXP) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Oxford Pharmascience Group Stock (LON:OXP) 30 days 90 days 365 days Advanced Chart Get OXP alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume16,260 shsAverage Volume803,502 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Oxford Pharmascience Group plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in re-developing medicines. The Company primarily engages in research and development activities based around its core technology platforms and focuses on commercializing the related products to pharmaceutical organizations. It operates through one segment, being the development and commercialization of drug products from proprietary technology platforms. The Company operates in three main geographic areas, such as the United Kingdom, Middle East and Brazil. The Company is primarily focused on commercialization efforts for its compounds OXPzero Ibuprofen and OXPzero Naproxen and in regulatory, technical and clinical activities in support of these assets. It is focused on establishing a number of commercial partnerships that demonstrate the commercial feasibility of the technology. The Company's subsidiaries include Oxford Pharmascience Limited and Oxford Nutra Limited. Read More Receive OXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford Pharmascience Group and its competitors with MarketBeat's FREE daily newsletter. Email Address OXP Stock News HeadlinesPharmascience Canada launches another generic drug with multiple indicationsFebruary 12, 2023 | finance.yahoo.comSee More Headlines OXP Stock Analysis - Frequently Asked Questions How do I buy shares of Oxford Pharmascience Group? Shares of OXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Oxford Pharmascience Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford Pharmascience Group investors own include Oxford Biomedica (OXB), Man Group (EMG), Aphria (APHA), Aphria (APHA), International Biotechnology (IBT), Richland Resources Ltd (RLD.L) (RLD) and The Restaurant Group (RTN). Industry, Sector and Symbol Stock ExchangeLON SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryN/A Current SymbolLON:OXP CIKN/A Webwww.oxfordpharmascience.com Phone+44-20-75545875FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (LON:OXP) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Pharmascience Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Pharmascience Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.